We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

106 hedge funds and large institutions have $115M invested in Rigel Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

886% more call options, than puts

Call options by funds: $887K | Put options by funds: $90K

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

0.28% less ownership

Funds ownership: 6.37% → 6.09% (-0.28%)

10% less funds holding

Funds holding: 118 → 106 (-12)

20% less capital invested

Capital invested by funds: $143M → $115M (-$28M)

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
106
Holders Change
-12
Holders Change %
-10.17%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
34
Reduced
34
Closed
17
Calls
$887K
Puts
$90K
Net Calls
+$797K
Net Calls Change
-$206K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$3.75M
2
VOYA Investment Management
VOYA Investment Management
Georgia
+$1.39M
3
SCM
Soleus Capital Management
Connecticut
+$752K
4
GCP
GSA Capital Partners
United Kingdom
+$737K
5
BCM
Bridgeway Capital Management
Texas
+$264K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$2.49M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.79M
3
Millennium Management
Millennium Management
New York
-$1.66M
4
TA
Tamarack Advisers
California
-$1.61M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$603K -$12.2K -1,018 -2%
Los Angeles Capital Management
27
Los Angeles Capital Management
California
$437K +$1.13K +94 +0.2%
AllianceBernstein
28
AllianceBernstein
Tennessee
$340K -$14.7K -1,225 -4%
Two Sigma Investments
29
Two Sigma Investments
New York
$290K -$1.79M -148,723 -85%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$268K -$637K -52,970 -68%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$247K +$866 +72 +0.3%
JP Morgan Chase
32
JP Morgan Chase
New York
$231K -$68.6K -5,699 -21%
Fidelity Investments
33
Fidelity Investments
Massachusetts
$219K +$2.74K +228 +1%
NSEDCP
34
NJ State Employees Deferred Compensation Plan
New Jersey
$216K – – –
Russell Investments Group
35
Russell Investments Group
United Kingdom
$209K -$21.5K -1,790 -8%
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$192K +$159K +13,191 +287%
SO
37
STRS Ohio
Ohio
$191K – – –
XT
38
XTX Topco
Cayman Islands
$177K +$130K +10,778 +191%
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$134K -$31.9K -2,648 -18%
Principal Financial Group
40
Principal Financial Group
Iowa
$132K +$26.4K +2,196 +22%
WMSA
41
Weiss Multi-Strategy Advisers
New York
$129K -$16.9K -1,403 -11%
CWM
42
Connecticut Wealth Management
Connecticut
$124K – – –
Allspring Global Investments
43
Allspring Global Investments
North Carolina
$113K +$28.3K +2,353 +29%
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$109K +$1.66K +138 +1%
Bank of America
45
Bank of America
North Carolina
$106K +$4.29K +357 +4%
Invesco
46
Invesco
Georgia
$101K +$6.34K +527 +6%
MIM
47
MetLife Investment Management
New Jersey
$100K – – –
SOW
48
State of Wyoming
Wyoming
$93.1K +$24.9K +2,073 +32%
AIG
49
American International Group
New York
$92.2K +$3.65K +303 +4%
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$88.4K +$337 +28 +0.3%
1
2
3 4 5

RIGL Hedge Fund Activity: Q3 2023 in Review

106 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2023, worth a combined $115M — down 20% from $143M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of RIGL and 6 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Morgan Stanley, adding an estimated $3.75M. The largest seller was Vanguard Group, cutting an estimated $2.49M.

  • 106 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2023, down from 118 in Q2 2023.
  • Funds reported $115M of Rigel Pharmaceuticals stock for Q3 2023, down 20% quarter-over-quarter.
  • 6 funds opened new Rigel Pharmaceuticals positions in Q3 2023 and 17 closed out, a net change of -11 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2023 was Morgan Stanley, an estimated $3.75M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2023 was Vanguard Group, an estimated $2.49M sold.

Based on aggregated 13F filings for Q3 2023.